Atlas Trials

Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors

Clinical trial NCT00703638 · COMPLETED

Trial details

NCT number
NCT00703638
Sponsor
Masonic Cancer Center, University of Minnesota
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Breast CancerColorectal CancerHead and Neck CancerLung CancerMesotheliomaPancreatic CancerProstate CancerSarcoma
Start date
2008-05-01
Primary completion
2010-09-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.